Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Bharat Serums & Vaccines Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Bharat Serums & Vaccines Ltd. Share Price

BSE Share Price
Not Listed

Bharat Serums & Vaccines Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Bharat Serums & Vaccines Ltd. Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.2
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
17.32%
Return on Capital Employed (ROCE)
23.86%
Return on Assets (ROA)
12.19%
Operating Profit Margin
16.9%
Net Profit Margin
10.82%
Gross Profit Margin
18%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
1.26%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
50.91%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
93.98%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
₹0 Cr.
Face Value
₹5
All Time Low / High
- / -

Bharat Serums & Vaccines . - (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % ⓘ4.7%13.6%9.8%13.7%17.3%15.1%22.2%29.1%14.9%21.4%-
Value Creation
Index ⓘ		-0.70.0-0.30.00.20.10.61.10.10.5-

Growth Parameters ⓘ
Sales ⓘ265349364493560623706787800810810
Sales YoY Gr.-31.7%4.3%35.3%13.6%11.2%13.2%11.5%1.6%1.3%-
Adj EPS ⓘ3.118.713.820.42424.93750.720.549.50
YoY Gr.-513.4%-26.1%47.9%17.3%4%48.3%37.2%-59.6%141.2%-
BVPS (₹) ⓘ106.6123.7133.8147.6162.2169.9207.5258.8294.5345.90
Adj Net
Profit ⓘ		5.23223.73540.446.769.395.63789.20
Cash Flow from Ops. ⓘ-2.659.132.341.543.762.674.214339.5105-
Debt/CF from Ops. ⓘ-58.42.45.53.74.32.51.70.30.20.4-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ13.2%7.6%4.7%1.3%
Adj EPS ⓘ36.3%15.6%10.2%141.2%
BVPSⓘ14%16.4%18.6%17.4%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on
Equity % ⓘ		2.916.110.714.415.315.819.621.87.315.50
Op. Profit
Mgn % ⓘ		8.816.614.717.416.716.117.220.911.917.3NAN
Net Profit
Mgn % ⓘ		29.26.57.17.27.59.812.14.6110
Debt to
Equity ⓘ		0.80.70.80.60.70.50.30.100.1-
Working Cap
Days ⓘ		1951721991822031991831771972480
Cash Conv.
Cycle ⓘ		107869082103111104931031030

Valuation of Bharat Serums & Vaccines Ltd. - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Sales598.05670.79742.95877.92896.59925.71
Operating Expenses ⓘ + 494.92565.02612.43696.53792.64768.85
Manufacturing Costs45.0744.4873.8690.6523.7322.66
Material Costs197.46245.29255.45287.97307.65315.69
Employee Cost 104.40119.18139.23156.31186.50199.37
Other Costs ⓘ 148156.07143.89161.60274.77231.13
Operating Profit ⓘ 103.13105.77130.52181.39103.94156.86
Operating Profit Margin (%) 17.2%15.8%17.6%20.7%11.6%16.9%
Other Income ⓘ + 9.4213.2013.856.9020.4315.80
Exceptional Items ⓘ 0-12.290000
Interest ⓘ 21.1222.3615.0411.258.856
Depreciation ⓘ 30.1532.6529.8026.4041.3325.52
Profit Before Tax ⓘ 61.2951.6899.53150.6374.19141.14
Tax ⓘ 11.778.4220.1546.8722.5540.97
Profit After Tax 49.5143.2679.37103.7651.64100.17
PAT Margin (%) 8.3%6.5%10.7%11.8%5.8%10.8%
Adjusted EPS (₹)29.123.142.455.128.755.6
Dividend Payout Ratio (%)4.70%6%0%0%0%0%
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21

Equity and Liabilities

Shareholders Fund + 255.96299.87378.65488.37526.52630.16
Share Capital ⓘ 9.929.379.379.429.019.01
Reserves ⓘ 246.04290.51369.28478.95517.51621.15
Debt +181.96145.48125.5741.3326.2850.34
Long Term Debt63.0835.3447.6135.889.209.27
Short Term Debt118.89110.1577.965.4517.0841.07
Minority Interest01111.411.41
Trade Payables36.9032.6359.5870.7100
Others Liabilities ⓘ 132.58119.4891.3898.14190.47217.43
Total Liabilities ⓘ 607.39598.47656.18699.54744.67899.35

Fixed Assets

Net Fixed Assets ⓘ +180.57180.77218.53250.71173.80175.75
Gross Block326.75212.19280.36336.29280.74299.79
Accumulated Depreciation146.1831.4361.8385.57106.94124.03
CWIP ⓘ 54.9675.0255.6515.1912.013.28
Investments ⓘ 0000010.09
Inventories137.57140.60143.15170.16220.56199.86
Trade Receivables98.61119.42145.91161.65152.14219.40
Cash Equivalents 14.4711.7613.312577.4975.59
Others Assets ⓘ 121.2170.9079.6476.82108.67215.38
Total Assets ⓘ 607.39598.47656.18699.54744.67899.35
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Cash Flow From Operating Activity ⓘ + 49.1270.7177.37134.9063.05122.28
PBT ⓘ 61.2951.6899.53150.6374.19141.14
Adjustment ⓘ 47.2549.7640.1338.1662.6438.50
Changes in Working Capital ⓘ -46.67-42.14-42.04-27.4-42.74-33.02
Tax Paid ⓘ -13.81-8.62-15.96-32.82-31.04-24.34
Cash Flow From Investing Activity ⓘ + -30.73-46.66-38.93-18.2338.21-133.11
Capex 2.08-47.03-41.56-18.1032.38-21.14
Net Investments 000000
Others ⓘ -32.810.372.63-0.135.82-111.97
Cash Flow From Financing Activity ⓘ + -14.28-24.42-36.54-110.38-37.783.15
Net Proceeds from Shares ⓘ 0300000
Net Proceeds from Borrowing ⓘ 0-28.7200-25.32-16.40
Interest Paid ⓘ -18.58-20.230000
Dividend Paid ⓘ -5.47-1.13-3.43-6.2500
Others ⓘ 9.77-4.34-33.11-104.13-12.4619.55
Net Cash Flow ⓘ 4.11-0.381.906.2863.48-7.67
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Ratios
ROE (%)19.4615.6123.423.9310.1817.32
ROCE (%)17.6215.823.0130.1815.1123.86
Asset Turnover Ratio0.991.131.191.31.241.13
PAT to CFO Conversion(x)0.991.630.971.31.221.22
Working Capital Days
Receivable Days59.9058.6064.9063.9063.9073.30
Inventory Days83.6074.7069.5065.1079.5082.90
Payable Days68.2051.7065.9082.6041.900

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bharat Serums & Vaccines Ltd. - (Amalgamated) FAQs

The current trading price of Bharat Serums & Vaccines Ltd. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Bharat Serums & Vaccines Ltd. stood at ₹0.00 Cr

The latest P/E ratio of Bharat Serums & Vaccines Ltd. as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Bharat Serums & Vaccines Ltd. as of 31-Dec-1969 is 0.00.

The 52-week high of Bharat Serums & Vaccines Ltd. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bharat Serums & Vaccines Ltd. is ₹810 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Bharat Serums & Vaccines Ltd. - (Amalgamated)

No data to display
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now